First Republic Investment Management, Inc. Pacira Bio Sciences, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 11,185 shares of PCRX stock, worth $212,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,185

Previous 10,595 5.57%

Holding current value

$212,291

Previous $424,000 19.1%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$30.68 - $40.09 $18,101 - $23,653	590 Added 5.57%	11,185 $343,000
Q2 2023 Jul 28, 2023	SELL	$36.12 - $47.5 $408,986 - $537,842	-11,323 Reduced 51.66%	10,595 $424,000
Q1 2023 May 11, 2023	BUY	$35.53 - $43.38 $214,352 - $261,711	6,033 Added 37.98%	21,918 $894,000
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $288,487 - $433,977	-7,554 Reduced 32.23%	15,885 $613,000
Q3 2022 Nov 03, 2022	BUY	$51.24 - $58.89 $184,207 - $211,709	3,595 Added 18.12%	23,439 $1.25 Million
Q2 2022 Aug 16, 2022	SELL	$51.49 - $81.64 $242,157 - $383,952	-4,703 Reduced 19.16%	19,844 $1.16 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $891,685 - $1.14 Million	-14,854 Reduced 37.7%	24,547 $1.87 Million
Q4 2021 Feb 09, 2022	BUY	$47.97 - $62.21 $219,894 - $285,170	4,584 Added 13.17%	39,401 $2.37 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $8,141 - $9,133	149 Added 0.43%	34,817 $1.95 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $952,620 - $1.13 Million	16,097 Added 86.68%	34,668 $2.1 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $935,674 - $1.24 Million	-15,776 Reduced 45.93%	18,571 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $861,623 - $1.13 Million	17,072 Added 98.82%	34,347 $2.06 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $126,962 - $153,909	2,443 Added 16.47%	17,275 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $178,670 - $304,378	5,801 Added 64.23%	14,832 $778,000
Q1 2020 May 13, 2020	BUY	$28.4 - $50.7 $36,607 - $65,352	1,289 Added 16.65%	9,031 $303,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $22,330 - $28,800	-615 Reduced 7.36%	7,742 $351,000
Q3 2019 Nov 08, 2019	BUY	$35.66 - $44.99 $86,939 - $109,685	2,438 Added 41.19%	8,357 $318,000
Q2 2019 Aug 07, 2019	SELL	$36.57 - $47.97 $40,007 - $52,479	-1,094 Reduced 15.6%	5,919 $257,000
Q1 2019 Apr 30, 2019	SELL	$36.47 - $42.17 $17,031 - $19,693	-467 Reduced 6.24%	7,013 $267,000
Q4 2018 Feb 12, 2019	BUY	$41.31 - $52.16 $92,369 - $116,629	2,236 Added 42.64%	7,480 $322,000
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $172,265 - $272,688	5,244 New	5,244 $258,000
Q1 2018 May 10, 2018	SELL	$29.98 - $46.35 $131,732 - $203,661	-4,394 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$31.85 - $46.95 $139,948 - $206,298	4,394	4,394 $201,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Pacira Bio Sciences, Inc. Transaction History